Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP — Anne Moscona (WASHINGTON UNIV
SUMMARY. The Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVAMPP Center will utilize both well-defined and novel approaches to develop proto
| Project title | Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP |
|---|---|
| Project number | 1U19AI181984-01 |
| PI name | Anne Moscona |
| Institution | WASHINGTON UNIVERSITY |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $44.11M |
| Fiscal year | 2024 |
| Project start | 2024-09-11T00:00:00 |
| Project end | 2027-08-31T00:00:00 |
| Abstract | SUMMARY. The Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVAMPP Center will utilize both well-defined and novel approaches to develop proto |
| Key terms | <Amino Acid Sequence><Animal Disease Models><Animal Model><Animal Models and Related Studies><Antibo |
$799/mo
Try GrantRadar →